C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors
Condition(s):Advanced CancerLast Updated:January 7, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Advanced CancerLast Updated:January 7, 2019Completed
Condition(s):Advanced CancerLast Updated:March 30, 2023Recruiting
Condition(s):Advanced Or Metastatic Solid Tumor MalignanciesLast Updated:March 28, 2023Recruiting
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:May 8, 2023Recruiting
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:February 20, 2024Recruiting
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:October 27, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:November 15, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:January 31, 2024Recruiting
Condition(s):Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsLast Updated:October 6, 2023Terminated
Condition(s):Advanced Solid Tumours That Are MTAP DeficientLast Updated:February 29, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.